tirzepatide and blood sugar vs Mounjaro: What's the Difference? Tirzepatide Injections: A New Breakthrough

Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ

Stopping Qsymia requires a gradual taper

Scripps Research senior program director Julia Moore Vogel is currently planning a long COVID trialnot funded by RECOVER but instead by the Schmidt Initiative for Long Covidusing tirzepatide

It falls under a group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the action of native GLP-1 hormone

Most people begin at a low starting point and gradually move up over weeks or months until they reach a dose that produces steady weight loss with manageable side effects

doi: 10.2147/DMSO.S182406